Literature DB >> 2516458

Summary of patient data from a multidisciplinary neurofibromatosis clinic.

E K Schorry1, D W Stowens, A H Crawford, P A Stowens, W R Schwartz, P S Dignan.   

Abstract

The Neurofibromatosis Clinic of the Children's Hospital Medical Center in Cincinnati, Ohio, is a multidisciplinary clinic which provides comprehensive care for persons affected with neurofibromatosis. Data are presented on 78 patients who fulfill the diagnostic criteria for neurofibromatosis-1. The information reported includes patient characteristics, complications and testing results.

Entities:  

Mesh:

Year:  1989        PMID: 2516458

Source DB:  PubMed          Journal:  Neurofibromatosis        ISSN: 1010-5662


  5 in total

Review 1.  Spinal deformity in neurofibromatosis type-1: diagnosis and treatment.

Authors:  Athanasios I Tsirikos; Asif Saifuddin; M Hilali Noordeen
Journal:  Eur Spine J       Date:  2005-02-15       Impact factor: 3.134

2.  Nutraceuticals safety and efficacy in migraine without aura in a population of children affected by neurofibromatosis type I.

Authors:  Marco Carotenuto; Maria Esposito
Journal:  Neurol Sci       Date:  2013-03-27       Impact factor: 3.307

3.  Central nervous system imaging in reevaluation of patients with neurofibromatosis type 1.

Authors:  P Balestri; L Calistri; R Vivarelli; G Bartalini; L Mancini; A Berardi; A Fois
Journal:  Childs Nerv Syst       Date:  1993-12       Impact factor: 1.475

4.  Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966.

Authors:  Christina Bergqvist; Amandine Servy; Laurence Valeyrie-Allanore; Salah Ferkal; Patrick Combemale; Pierre Wolkenstein
Journal:  Orphanet J Rare Dis       Date:  2020-02-03       Impact factor: 4.123

Review 5.  Neurofibromatosis type 1 in genetic counseling practice: recommendations of the National Society of Genetic Counselors.

Authors:  Heather B Radtke; Courtney D Sebold; Caroline Allison; Joy Larsen Haidle; Gretchen Schneider
Journal:  J Genet Couns       Date:  2007-07-17       Impact factor: 2.537

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.